FdaApplication
BLA 761216
Identifiers
- fda_app_no: BLA761216
Properties
| Property | Value |
|---|---|
| applicant_name | Emerge Bioscience Pte. Ltd. |
| application_type | BLA |
| approval_date | 2021-12-17 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| YUSIMRY | ADALIMUMAB-AQVH | 40MG/0.8ML | Injection |
| YUSIMRY | — | 40MG/0.8ML | Injection |
| YUSIMRY | — | 80MG/0.8ML | Injection |
| YUSIMRY | — | 40MG/0.4ML | Injection |
4 products